Statistics
Publications
14
Citations
3.6K
H-Index
14
Active since
2014
Josef Leibold is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, molecular oncology, and life sciences.
Publications per year
2014–2024
14
14
Senolytic CAR T cells reverse senescence-associated pathologies
Corina Amor, Judith Feucht, Josef Leibold et al. · Nature · 2020 · 1K citations · Full text
Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency
Judith Feucht, Jie Sun, Justin Eyquem et al. · Nature Medicine · 2018 · 543 citations · Full text
NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination
Marcus Ruscetti, Josef Leibold, Matthew J. Bott et al. · Science · 2018 · 433 citations · Full text
Life Sciences, Immunology, Oncology +17
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer
Marcus Ruscetti, John P. Morris, Riccardo Mezzadra et al. · Cell · 2020 · 416 citations · Full text
Medicine, Cancer Biology, Oncology +12
In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer
Ramona Rudalska, Daniel Dauch, Thomas Longerich et al. · Nature Medicine · 2014 · 277 citations · Full text
1–5 of 14